BioengineeringGut MicrobesPeer-reviewed
Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic
B. M. Mortzfeld, J. D. Palmer, S. K. Bhattarai…·V. Bucci
This paper demonstrates that engineered live biotherapeutic Escherichia coli producing microcin MccI47 reduces carbapenem-resistant Klebsiella pneumoniae colonization in mice without disrupting the microbiota.
DOI 10.1080/19490976.2022.2127633